XML 26 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Leases
9 Months Ended
Sep. 30, 2021
Leases [Abstract]  
Leases Leases
The Company leases facilities in Ann Arbor, Michigan and Cambridge, Massachusetts. The Ann Arbor facility includes office space, and the Cambridge facilities include clean rooms, laboratories for MACI and Epicel manufacturing and office space. The Company also leases offsite warehouse space, vehicles and computer equipment. Certain of the Company’s lease agreements include lease payments that are adjusted periodically for an index or rate. The leases are initially measured using the present value of the projected payments adjusted for the index or rate in effect at the commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. All operating lease commitments with a lease term greater than 12 months are recognized as right-of-use assets and liabilities, on a discounted basis on the balance sheet. Effective October 21, 2020 the Company entered into an agreement with one of its Cambridge, Massachusetts facility leases. The agreement extended the terms of the lease to expire on February 29, 2032, with monthly contractual lease payments ranging from $0.4 million to $0.6 million. The agreement also provides a tenant improvement allowance of approximately $4.3 million, available through December 31, 2023.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. For both the three and nine months ended September 30, 2021 and 2020, lease expense of less than $0.1 million was recorded for each of short-term leases and financing leases. During the nine months ended September 30, 2021, the Company recorded $0.4 million of leasehold improvements funded by tenant improvement allowances available under the lease agreements. The contribution toward the cost of tenant improvements is recorded as a reduction of the operating lease assets. For the three and nine months ended September 30, 2021, the Company recognized $1.8 million and $5.5 million, respectively, of operating lease expense and $1.6 million and $4.5 million, respectively for the same periods in 2020. The Company’s leases contain non-lease components and activities that do not transfer a good or service to the Company. The Company elected not to combine lease and non-lease components and therefore non-lease costs were not included in the net lease assets or lease liabilities.

Total leased assets and liabilities classified on the balance sheet, as of September 30, 2021 and December 31, 2020 are as follows:

(In thousands)ClassificationSeptember 30, 2021December 31, 2020
Assets
OperatingRight-of-use assets$46,713 $50,105 
FinanceProperty and equipment, net83 111 
Total leased assets$46,796 $50,216 
Liabilities
Current
OperatingCurrent portion of operating lease liabilities$2,280 $4,394 
FinanceOther liabilities41 41 
$2,321 $4,435 
Non-current
OperatingOperating lease liabilities$48,493 $48,789 
FinanceOther long-term liabilities42 76 
Total leased liabilities$48,535 $48,865 
Leases Leases
The Company leases facilities in Ann Arbor, Michigan and Cambridge, Massachusetts. The Ann Arbor facility includes office space, and the Cambridge facilities include clean rooms, laboratories for MACI and Epicel manufacturing and office space. The Company also leases offsite warehouse space, vehicles and computer equipment. Certain of the Company’s lease agreements include lease payments that are adjusted periodically for an index or rate. The leases are initially measured using the present value of the projected payments adjusted for the index or rate in effect at the commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. All operating lease commitments with a lease term greater than 12 months are recognized as right-of-use assets and liabilities, on a discounted basis on the balance sheet. Effective October 21, 2020 the Company entered into an agreement with one of its Cambridge, Massachusetts facility leases. The agreement extended the terms of the lease to expire on February 29, 2032, with monthly contractual lease payments ranging from $0.4 million to $0.6 million. The agreement also provides a tenant improvement allowance of approximately $4.3 million, available through December 31, 2023.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. For both the three and nine months ended September 30, 2021 and 2020, lease expense of less than $0.1 million was recorded for each of short-term leases and financing leases. During the nine months ended September 30, 2021, the Company recorded $0.4 million of leasehold improvements funded by tenant improvement allowances available under the lease agreements. The contribution toward the cost of tenant improvements is recorded as a reduction of the operating lease assets. For the three and nine months ended September 30, 2021, the Company recognized $1.8 million and $5.5 million, respectively, of operating lease expense and $1.6 million and $4.5 million, respectively for the same periods in 2020. The Company’s leases contain non-lease components and activities that do not transfer a good or service to the Company. The Company elected not to combine lease and non-lease components and therefore non-lease costs were not included in the net lease assets or lease liabilities.

Total leased assets and liabilities classified on the balance sheet, as of September 30, 2021 and December 31, 2020 are as follows:

(In thousands)ClassificationSeptember 30, 2021December 31, 2020
Assets
OperatingRight-of-use assets$46,713 $50,105 
FinanceProperty and equipment, net83 111 
Total leased assets$46,796 $50,216 
Liabilities
Current
OperatingCurrent portion of operating lease liabilities$2,280 $4,394 
FinanceOther liabilities41 41 
$2,321 $4,435 
Non-current
OperatingOperating lease liabilities$48,493 $48,789 
FinanceOther long-term liabilities42 76 
Total leased liabilities$48,535 $48,865